Dental Tobacco Control.Net:Improving Practice (DTC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00627185|
Recruitment Status : Completed
First Posted : February 29, 2008
Last Update Posted : March 9, 2015
|Condition or disease||Intervention/treatment||Phase|
|Tobacco Use Disorder||Behavioral: Internet-delivered continuing professional development Other: No intervention arm||Early Phase 1|
Tobacco use has been described as the number one behavioral health problem of our time with a projected 8.4 million total smoking related deaths worldwide by the year 2020. Current clinical practice guidelines entitled "Treating Tobacco Use and Dependence" provide a summary of evidence-based recommendations. Despite the evidence of tobacco risk and the efficacy of tobacco control interventions, 30% of current smokers report that they have never been advised to stop smoking by a healthcare provider. Nearly half (47.9%) of dentists report they have never intervened to assist tobacco users in quitting. Our intervention is designed to improve the rate of tobacco cessation advice delivered in dental practices.
This proposal is in response to the request for applications "Translational Research in Dental Practice-based Tobacco Control Interventions" (RFA: DE-03-007). Our exploration of barriers and facilitators will assist in clarifying processes that influence translation of tobacco-related knowledge into clinical dental practice. Our trial will integrate theoretically grounded methods of provider behavior change, medical informatics, and tobacco control research to translate guidelines into dental clinical practice. We will avoid a "one-size-fits-all" approach by tailoring strategies for tobacco cessation counseling to individual practices. The intervention will be longitudinal, with updates and continuous access for dentists and dental staff over 2 years. Our evaluation will extend from processes of care to patient outcomes. Ancillary analyses will assess differences in tobacco counseling rates associated with practice, provider, and patient-level variables including disparities in counseling by race. To assess the relative impact of various components of the multi-modal intervention, we will conduct secondary analyses of the association of amount of use of each specific component with frequency of tobacco cessation counseling within the intervention group.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||190 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Dental Tobacco Control.Net:Improving Practice|
|Study Start Date :||September 2003|
|Actual Primary Completion Date :||June 2008|
|Actual Study Completion Date :||August 2008|
Intervention group (dental practices) that received the interactive motivational website for patient tobacco cessation
Behavioral: Internet-delivered continuing professional development
Interactive motivational website for dentists and hygienists with practice improvement resources, discussion forum, and educational cases on cessation counseling with email reminders.
Placebo Comparator: 2
Control group (dental practices) that did not receive any materials or resources on tobacco cessation. This is a wait-list control.
Other: No intervention arm
- Our primary outcome measures are patient-reported provider delivered tobacco screening and tobacco cessation advice. [ Time Frame: Baseline, 8-months post-intervention, and 24-months post-intervention ]
- Point prevalence smoking cessation [ Time Frame: six-months after index visit for patients who smoke ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00627185
|United States, Alabama|
|University of Alabama at Birmingham|
|Birmingham, Alabama, United States, 35294|
|Principal Investigator:||Thomas K Houston, MD||University of Alabama at Birmingham|